CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
✎ GovInfoNow plain-language explainer
Hikma Pharmaceuticals USA Inc. is recalling 20,335 bottles of Ciprofloxacin Tablets, USP, 750 mg because they contain N-nitroso-ciprofloxacin above the FDA's recommended interim control limit. This impurity can form during manufacturing if Good Current Manufacturing Practices (CGMP) are not followed. The recall covers specific lots distributed nationwide. Read more at govinfonow.com/recall/2249335-hikma-pharmaceuticals-usa-inc-recalls-ciprofloxacin-tablets-usp-750-mg.
“Hikma Recalls Ciprofloxacin 750mg Due to Impurity.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2249335-hikma-pharmaceuticals-usa-inc-recalls-ciprofloxacin-tablets-usp-750-mg. Based on FDA recall #D-0166-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0166-2027%22&limit=1).
The FDA announced on Oct. 20, 2026, that Hikma Pharmaceuticals USA Inc. voluntarily recalled Ciprofloxacin Tablets, USP, 750 mg due to CGMP deviations resulting in N-nitroso-ciprofloxacin levels exceeding the agency's recommended interim control limit.
According to the FDA, the recall addresses CGMP deviations where N-nitroso-ciprofloxacin results were found above the FDA recommended interim control limit.
Context
GovInfoNow's records show Hikma Pharmaceuticals USA Inc. has 16 other recalls on record since Dec. 17, 2019. Other recent recalls of similar products include Abirtega Tablets (Oct. 6, 2026), Ramipril Capsules (Aug. 24, 2026), and Alendronate Sodium Oral Solution (April 7, 2026). Other recent recalls of similar products include Fosfomycin Tromethamine Granules (Sept. 18, 2026), Furosemide 80mg (March 20, 2026), and Prazosin Capsules (March 27, 2026).
How to tell if you have this one
Check your bottle for NDC 0143-9929-50 and look for one of the following lot numbers: CA083A, CA084A, or CA085A. Verify that the expiration date is 12/31/2026. The product is a 50-count bottle of Rx-only tablets.
Brand
Hikma Pharmaceuticals
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0166-2027 (October 20, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0166-2027 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.